Femasys (FEMY) Net Income towards Common Stockholders (2020 - 2025)

Femasys (FEMY) posted Net Income towards Common Stockholders of -$4.6 million for Q2 2025, up 22.23% on a QoQ basis from -$5.9 million in Q1 2025, and up 2.11% year-over-year from -$4.5 million in Q2 2024.

Femasys (FEMY) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends

Femasys' Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$4.6 million for Q2 2025.

  • Quarterly Net Income towards Common Stockholders rose 2.11% year-over-year to -$4.6 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 78.28% YoY) and the FY2025 annual result came in at -$18.6 million, up 1.0% from the prior year.
  • Net Income towards Common Stockholders was -$4.6 million for Q2 2025 at Femasys, up from -$5.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$1.1 million in Q2 2021 and bottomed at -$5.9 million in Q1 2025.
  • A 5-year average of -$3.5 million and a median of -$3.0 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders increased 27.09% — and 2022, when it slumped 143.21%.
  • Femasys' Net Income towards Common Stockholders stood at -$2.4 million in 2021, then fell by 22.38% to -$2.9 million in 2022, then tumbled by 52.39% to -$4.4 million in 2023, then fell by 16.17% to -$5.1 million in 2024, then rose by 10.5% to -$4.6 million in 2025.
  • Business Quant data shows FEMY's Net Income towards Common Stockholders at -$4.6 million in Q2 2025, -$5.9 million in Q1 2025, and -$5.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.93 Bn 121.71 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.94 Bn 44.13 Bn 2.15 Bn -274.00 Mn
3 Alcon 33.13 Bn 31.47 Bn 1.53 Bn 22.13 Bn
4 Medline 32.87 Bn 30.63 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.48 Bn 27.82 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.28 Bn 22.84 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.11 Bn 13.55 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.80 Bn 13.66 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.06 Bn 11.00 Bn 736.59 Mn 112.77 Mn
10 Femasys 14.23 Mn 8.85 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -4.59 Mn
Mar 31, 2025 -5.90 Mn
Dec 31, 2024 -5.12 Mn
Sep 30, 2024 -5.41 Mn
Jun 30, 2024 -4.68 Mn
Mar 31, 2024 -3.60 Mn
Dec 31, 2023 -4.41 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 -2.89 Mn
Mar 31, 2023 -2.95 Mn
Dec 31, 2022 -2.89 Mn
Sep 30, 2022 -2.98 Mn
Jun 30, 2022 -2.63 Mn
Mar 31, 2022 -2.88 Mn
Dec 31, 2021 -2.36 Mn
Sep 30, 2021 -2.26 Mn
Jun 30, 2021 -1.08 Mn
Mar 31, 2021 -1.83 Mn
Dec 31, 2020 -1.66 Mn
Sep 30, 2020 -1.57 Mn